Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
| Trades 19 | Longs Won 11/19 57% | Profit Factor 3.09 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $16,153.94 |
| Average Win $12,275.51 | Best Trade (Jun 19) $47,488.24 | Sharpe Ratio -23.47 |
| Average Loss -$5,468.66 | Worst Trade (May 23) -$23,027.51 | Z-Score -0.37 (28.87%) |
| Commissions $0 | Avg. Trade Length 1m 3w 6d | Expectancy $4,804.28 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | 0.03% | 0.21% | 0.93% | 3.19% | 9.03% | 22.22% | 49.15% |
| Consecutive Losing Trades | 35 | 31 | 28 | 24 | 21 | 17 | 14 | 10 | 7 | 3 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
MYGN Myriad Genetics Inc. | 33,208.56 | $150,766.86 | $191,281.31 | - | $40,514.45 | 26.87% | +36.817% |